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Public health crisis caused by severe epidemic diseases leads to a hot debate on 
how to balance the patent holder’s interests and public interests. Compulsory license 
of pharmaceutical patents, as the most effective method to promote access to 
medicines, becomes the focus of the debate. 
This thesis does research on public health problem and compulsory license system 
of pharmaceutical patents under WTO, which is divided into four chapters. 
Chapter One introduces formation and general principles of the compulsory 
license, including brief history of compulsory license, definition and characters of 
compulsory license as well as relevant legislation. It attaches importance to the 
relationship between public health crisis and compulsory license of pharmaceutical 
patents. Compared with traditional compulsory license, it points out particularity of 
international application of compulsory license of pharmaceutical patents. 
Chapter Two describes the structure of compulsory license system of 
pharmaceutical patents under WTO. Based on Article 31 of TRIPS Agreement, 
Declaration, Decision and Amendment to TRIPS Agreement, it analyzes the above 
legal documents as the core, and particularly dissects the relationship between these 
documents. The chapter presents international law on compulsory license of 
pharmaceutical patents on the whole. 
Chapter Three eleborates barriers to practice of compulsory license of 
pharmaceutical patents from the angle of theory. Firstly, it analyzes deficiencies of 
existing provisions. Complicated application arrangement, lack of obligation to 
authorization, pending problems are barriers within the System. Secondly, it discusses 
barriers beyond the System from the angle of practice, which includes the impact of 
developed countries’ polices on intellectual property rights and subsequent legislation, 
as well as pharmaceutical enterprises’ industry strategy. 
Chapter Four proposes assumptions on how to perfect compulsory license system 
of pharmaceutical patents under WTO. It involves deficient provisions within the 
System, but also introduces other applicable methods contributive to resolve public 
health problems. 
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至 20 世纪 90 年代初，世界上已经约有 100 多个国家承认了强制许可，授予
许可的理由也从“不实施”扩展到其他情势，诸如公共利益、国家安全、政府使
用和反竞争行为的救济。③作为 WTO 协议重要组成部分的《与贸易有关的知识
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